The antihyperglycemic effect of Bridelia ndellensis ethanol extract and its fractions is mediated by an insulinotropic action

DOI: 10.4236/jdm.2013.33016   PDF   HTML     3,254 Downloads   4,978 Views   Citations

Abstract

Backgroung: Bridelia ndellensis (Euphorbiaceae) is used as a traditional plant treatment of diabetes. The aim of the present study was to investigate the mechanism involved in the antihyperglycemic effects of this plant. Methods: An intestinal perfusion technique was used to study the effect of the ethanol extract of B. ndellensis on the intestinal absorption of glucose in normal rats fasted for 36 h. The effect of the extract (50 and 100 mg/kg) on Insulin secretion was evaluated using BRIN-BD11 pancreatic cells. Results: In a perfused rat intestinal preparation in situ, the plant extract at a concentration of 5 mg/ml did not show any inhibitory effects on glucose absorption when compared with control animals. Ouabain which is an inhibitor of glucose transport across the small intestine significantly (p < 0.001) decreased the glucose absorption during the whole perfusion period compared with the control group. On the other hand, the plant extract inhibited the gastrointestinal motility induced by Barium sulphate milk in rats. The ethanol extract of B. ndellensis at concentrations of 50 and100mg/ml stimulated in a concentration-dependent manner the insulin secretion from BRIN-BD11 cells in vitro. The induction of insulin release was significantly different when compared to control with the concentration of 100 μg/ml (P < 0.001). Alanine (10 mM) used as positive control, significantly (p < 0.001) stimulated insulin release from BRIN-BD11 cells. Conclusion: The present study has revealed that B. ndellensis ethanol extract stimulates insulin secretion and does not affect the glucose absorption, and it has suggested that the antihyperglycemic effects of B. ndellensis is partly mediated by the stimulation of insulin secretion.

Share and Cite:

Sokeng, S. , Rokeya, B. , Hannan, J. , Ali, L. and Kamtchouing, P. (2013) The antihyperglycemic effect of Bridelia ndellensis ethanol extract and its fractions is mediated by an insulinotropic action. Journal of Diabetes Mellitus, 3, 111-115. doi: 10.4236/jdm.2013.33016.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Kwon, Y.I., Apostolidis, E. and Shetty, K. (2008) In vitro studies of egg-plant (Solanum melongena) phenolics as inhibitors of key enzymes relevant for type 2 diabetes and hypertension. Bioresource Technology, 99, 2981-2988. doi:10.1016/j.biortech.2007.06.035
[2] International Diabetes Federation (2006) Diabetes atlas, 3rd Edition. http://www.eatlas.idf.org
[3] World Health Organization (1980) Expert committee on diabetes mellitus. WHO Technical Report, Series No. 646, Geneva.
[4] Weragoda, P.B. (1980) Some questions about the future of traditional medicine in developing countries. Journal of Ethnopharmacology, 2, 193-194. doi:10.1016/0378-8741(80)90015-X
[5] Sokeng, S.D., Rokeya, B., Mostafa, M., Nahar, N., Mosihuzzaman, M., Ali, L. and Kamtchouing, P. (2005) Antihyperglycemic effect of Bridelia ndellensis ethanol extract and fractions in streptozotocin-induced diabetic rats. African Journal of Traditional Complementary and Alternative Medicines, 2, 94-102. http://hdl.handle.net/1807/9193
[6] Kamtchouing, P., Sokeng, S.D., Moundipa, P.F., Watcho, P., Jatsa, H.B. and Lontsi, D. (1998) Protective role of Anacardium occidentale extract against streptozotocininduced diabetes in rats. Journal of Ethnopharmacology, 62, 95-99. doi:10.1016/S0378-8741(97)00159-1
[7] WHO (2002) Traditional medicine strategy 2002-2005. World Health Organization, Geneva, 74 Pages. www.who.int/medicinedocs/fr/d/Js2297e
[8] Swintosky, J.V. and Pogonowskawala, E. (1982) The insitu rat gut technique. Pharmacy International, 3, 163-167.
[9] Barnes, C.D. and Eltherington, L.G. (1973) Drug dosage in lab animals; a handbook. 2nd Edition, University of California Press, Berkeley, 177 Pages.
[10] Sokeng, S.D., Rokeya, B., Hannan, J.M.A., Junaida, K., Zitech, P., Ali, L., Ngounou, G., Lontsi, D. and Kamtchouing, P. (2007) Inhibitory effect of Ipomoea aquatic extracts on glucose absorption using a perfused rat intestinal preparation. Fitoterapia, 78, 526-529. doi:10.1016/j.fitote.2007.06.011
[11] McClenaghan, N.H., Barnett, C.R., Ah-Sing, E., AbdelWahab, Y.H., O’Harte, F.P., Yoon, T.W., Swanston-Flatt, S.K. and Flatt, P.R. (1996) Characterisation of a novel glucose responsive insulin secreting cell line, BRIN BD11, produced by electrofusion. Diabetes, 45, 1132-1140. doi:10.2337/diab.45.8.1132
[12] Flatt, P. and Bailey, C.J. (1981) Abnormal plasma glucose and insulin response in heterozygous lean (ob/+) mice. Diabetologia, 20, 573-577. doi:10.1007/BF00252768
[13] Hunt, S.M., Chrznowska, C., Barnett, C.R., Brand, H.N. and Fawell, J.K. (1987) A comparison of in vitro cytotoxicity assays and their application to water samples. Alternatives to Laboratory Animals, 15, 20-29.
[14] Toeller, M. (1994) Alpha-glucosidase inhibitors in diabetes: Efficacy in NIDDM subjects. European Journal of Clinical Investigation, 24, 31-35. doi:10.1111/j.1365-2362.1994.tb02253.x
[15] Sababi, M. and Bengtsson, U.H. (2001) Enhance intestinal motility influences absorption in anesthetized rat. Acta Physiologica Scandinavica, 172, 115-122. doi:10.1046/j.1365-201X.2001.00849.x
[16] Gray, A.M., Abdel-Wahab, Y.H. and Flatt, P.R. (2000) The traditional plant treatment, Sambucus nigra (elder), Exhibits sulin-Like and Insulin-releasing actions in vitro. Journal of Nutrition, 130, 15-20.
[17] Kasabri, V., Flatt, P.R. and Abdel-Wahab, Y.H. (2010) Terminalia bellirica stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation in vitro. British Journal of Nutrition, 103, 212-217. doi:10.1017/S0007114509991577
[18] Mishra, A. and Joy, K.P. (2006) 2-Hydroxyestradiol-17betaInduced oocyte maturation: involvement of cAMP-protein kinase A and okadaic acid-sensitive protein phosphatases, and their interplay in oocyte maturation in the catfish Heteropneustes fossilis. Journal Experimental Biology, 209, 2567-2575. doi:10.1242/jeb.02270
[19] Nattrass, M. and Bailey, C.J. (1999) New agents for Type 2. Best Practice & Research Clinical Endocrinology & Metabolism, 13, 309-329. doi:10.1053/beem.1999.0023
[20] Mostafa, M., Nahar, N, Mosihuzzaman, M., Sokeng, S.D., Fatima, N., Atta-ur-Rahman and Choudhary, I.M. (2006) Phosphodiesterase-I inhibitor quinovic acid glycosides from Bridelia ndellensis. Natural Product Research, 20, 686-692. doi:10.1080/14786410600661658
[21] Leibowitz, M.D., Biswas, C., Brady, E.J., Conti, M., Culliman, C.A., Hayes, N.S., Manganielle, V.C., Saperstein, R., Wang, L., Zafian, P.T. and Berger, J. (1995) A novel insulin secretagogue is a phosphodiesterase inhibitor. Diabetes, 44, 66-74. doi:10.2337/diab.44.1.67
[22] Gribble, F.M. and Reimann, F. (2003) Sulphonylurea action revisited: The post-cloning era. Diabetologia, 46, 875-891. doi:10.1007/s00125-003-1143-3

  
comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.